NCT06771323View on ClinicalTrials.gov

Safety and Effectiveness of Valbenazine as Adjunct Therapy to Botulinum Toxin Injections in Cervical Dystonia

PHASE2RecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

December 17, 2024

Primary Completion Date

January 31, 2026

Study Completion Date

January 31, 2026

Conditions
Cervical Dystonia
Interventions
DRUG

Valbenazine

To assess if valbenazine 80mg daily improves motor symptoms in idiopathic CD patients with persistent symptoms despite current treated with botulinum toxin injections.

DRUG

Placebo

Placebo

Trial Locations (1)

23298

RECRUITING

Virginia Commonwealth University, Richmond

All Listed Sponsors
lead

Virginia Commonwealth University

OTHER